Cost-effectiveness analysis of mavacamten for obstructive hypertrophic cardiomyopathy: a perspective from the Chinese healthcare system
Crossref DOI link: https://doi.org/10.1136/openhrt-2025-003914
Published Online: 2026-02-20
Published Print: 2026-01
Update policy: https://doi.org/10.1136/crossmarkpolicy
Qian, Jialing https://orcid.org/0009-0008-3458-2009
Zhang, Jiahao
Jiang, Qingqing
Wu, Tingting
License valid from 2026-02-20
